Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
PURPOSE:To investigate the prognostic value of cavernoussinus invasion (CSI) in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT). PATIENTS AND METHODS:Retrospective review of data from 1,087 patients with biopsy-proven, non-metastatic NPC. All patient...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4732613?pdf=render |
_version_ | 1818369928107917312 |
---|---|
author | Jun-Fang Liao Li Ma Xiao-Jing Du Mei Lan Ying Guo Lie Zheng Yun-Fei Xia Wei Luo |
author_facet | Jun-Fang Liao Li Ma Xiao-Jing Du Mei Lan Ying Guo Lie Zheng Yun-Fei Xia Wei Luo |
author_sort | Jun-Fang Liao |
collection | DOAJ |
description | PURPOSE:To investigate the prognostic value of cavernoussinus invasion (CSI) in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT). PATIENTS AND METHODS:Retrospective review of data from 1,087 patients with biopsy-proven, non-metastatic NPC. All patients were diagnosed using magnetic resonance imaging (MRI) scans and received IMRT as the primary treatment. RESULTS:The incidence of cavernoussinus invasion in this cohort was 12.1%. In univariate analysis, 5-year overall survival (OS) (70.6% vs. 88.5%, P < 0.001) and distant metastasis-free survival (DMFS) (71.4% vs. 87.7%, P < 0.001), but not locoregional relapse-free survival (LRFS) (93.9% vs. 93.7%, P = 0.341), were significantly different between patients with and without cavernoussinus invasion. In the T4 subgroup, the 5-year OS, DMFS, and LRFS of patients with and without cavernoussinus extension were 70.6% vs. 81.9% (P = 0.011), 71.4% vs. 84.1% (P = 0.011), and 91.2% vs. 89.7% (P = 0.501), respectively. In multivariate analysis, cavernoussinus invasion was an independent prognostic factor for poorer OS (HR = 1.782; P = 0.013) and DMFS (HR = 1.771; P = 0.016), but not LRFS (HR = 0.632; P = 0.294). In patients with lymph node metastasis, the DMFS rates of patients with and without cavernoussinus invasion were significantly different (P < 0.001). Preliminaryanalysis indicated that neoadjuvant chemotherapy led to better DMFS and OS in patients with cavernoussinus invasion than concurrent chemotherapy or radiotherapy alone; however, the differences were not significant. CONCLUSIONS:In the IMRT era, cavernoussinus invasion remains a prognostic factor for poor DMFS and OS in NPC, even in patients with T4 disease. |
first_indexed | 2024-12-13T23:31:38Z |
format | Article |
id | doaj.art-20f1797896af4a03bdbe1e0331586a8f |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-13T23:31:38Z |
publishDate | 2016-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-20f1797896af4a03bdbe1e0331586a8f2022-12-21T23:27:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01111e014678710.1371/journal.pone.0146787Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.Jun-Fang LiaoLi MaXiao-Jing DuMei LanYing GuoLie ZhengYun-Fei XiaWei LuoPURPOSE:To investigate the prognostic value of cavernoussinus invasion (CSI) in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT). PATIENTS AND METHODS:Retrospective review of data from 1,087 patients with biopsy-proven, non-metastatic NPC. All patients were diagnosed using magnetic resonance imaging (MRI) scans and received IMRT as the primary treatment. RESULTS:The incidence of cavernoussinus invasion in this cohort was 12.1%. In univariate analysis, 5-year overall survival (OS) (70.6% vs. 88.5%, P < 0.001) and distant metastasis-free survival (DMFS) (71.4% vs. 87.7%, P < 0.001), but not locoregional relapse-free survival (LRFS) (93.9% vs. 93.7%, P = 0.341), were significantly different between patients with and without cavernoussinus invasion. In the T4 subgroup, the 5-year OS, DMFS, and LRFS of patients with and without cavernoussinus extension were 70.6% vs. 81.9% (P = 0.011), 71.4% vs. 84.1% (P = 0.011), and 91.2% vs. 89.7% (P = 0.501), respectively. In multivariate analysis, cavernoussinus invasion was an independent prognostic factor for poorer OS (HR = 1.782; P = 0.013) and DMFS (HR = 1.771; P = 0.016), but not LRFS (HR = 0.632; P = 0.294). In patients with lymph node metastasis, the DMFS rates of patients with and without cavernoussinus invasion were significantly different (P < 0.001). Preliminaryanalysis indicated that neoadjuvant chemotherapy led to better DMFS and OS in patients with cavernoussinus invasion than concurrent chemotherapy or radiotherapy alone; however, the differences were not significant. CONCLUSIONS:In the IMRT era, cavernoussinus invasion remains a prognostic factor for poor DMFS and OS in NPC, even in patients with T4 disease.http://europepmc.org/articles/PMC4732613?pdf=render |
spellingShingle | Jun-Fang Liao Li Ma Xiao-Jing Du Mei Lan Ying Guo Lie Zheng Yun-Fei Xia Wei Luo Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy. PLoS ONE |
title | Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy. |
title_full | Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy. |
title_fullStr | Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy. |
title_full_unstemmed | Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy. |
title_short | Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy. |
title_sort | prognostic value of cavernous sinus invasion in patients with nasopharyngeal carcinoma treated with intensity modulated radiotherapy |
url | http://europepmc.org/articles/PMC4732613?pdf=render |
work_keys_str_mv | AT junfangliao prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy AT lima prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy AT xiaojingdu prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy AT meilan prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy AT yingguo prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy AT liezheng prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy AT yunfeixia prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy AT weiluo prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy |